General Information of the Compound
Compound ID
CP0183314
Compound Name
6-Substituted 4-Anilinoquinazoline 15
    Show/Hide
Formula
C18H13BrN4O
Molecular Weight
381.233
Canonical SMILES
Brc1cccc(Nc2ncnc3ccc(NC(=O)C=C=C)cc23)c1
    Show/Hide
InChI
InChI=1S/C18H13BrN4O/c1-2-4-17(24)22-14-7-8-16-15(10-14)18(21-11-20-16)23-13-6-3-5-12(19)9-13/h3-11H,1H2,(H,22,24)(H,20,21,23)
    Show/Hide
InChIKey
AWZOTLBLGSFFML-UHFFFAOYSA-N
Physicochemical Property
logP
4.4155
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
66.91
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
SID: 15599932
ChEMBL ID
CHEMBL343722
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 120 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 1.6 nM